A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly
A phase 3 trial of Iberdomide, Lenalidomide in multiple myeloma, run by Bristol-Myers Squibb, active and no longer recruiting.
Overview
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma is a phase 3 interventional study registered as NCT05827016 by Bristol-Myers Squibb, with 1230 participants enrolled, started 2023-06-22 and due to reach its primary completion in 2029-03-15. Interventions recorded: Iberdomide, Lenalidomide. Conditions listed: Multiple Myeloma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialOpen-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants
Shares Iberdomide, Bristol Myers Squibb, Multiple myeloma.
- TrialA Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple
Shares Iberdomide, Bristol Myers Squibb, Multiple myeloma.
- TrialA Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
Shares Iberdomide, Lenalidomide, Multiple myeloma.
- TrialA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-spe
Shares Iberdomide, Lenalidomide, Multiple myeloma.
- TrialSafety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
Shares Lenalidomide, Multiple myeloma.
- TrialA Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alo
Shares Lenalidomide, Bristol Myers Squibb, Multiple myeloma.
- TechnologyCereblon E3 ligase modulators (CELMoDs)
Shares Iberdomide, Multiple myeloma.
- TrialStudy With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
Shares Lenalidomide, Multiple myeloma.